Skip to main content
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Nov 15;5(2):283–289. doi: 10.1158/1940-6207.CAPR-11-0257

Figure 4.

Figure 4

Multiplicity by lesion type. Significant flat atypia was detected in all treatment groups. Significant low-grade dysplasia was detected in middle- and high-dose groups, and high-grade dysplasia and SCC was only detected in the high-dose group. *p<0.05